Rezolute (RZLT) Shares Issued (2010 - 2026)
Rezolute recorded quarterly Shares Issued of $747000.0 in Q1 2026, up 109.83% quarter-over-quarter from $356000.0 in Q4 2025, and up 114.26% year-over-year from $348644.4 in Q1 2025.
Rezolute's Shares Issued history runs 13 years deep, the most recent figure standing at $747000.0 for Q1 2026.
- In Q1 2026, Shares Issued rose 114.26% year-over-year to $747000.0; the TTM figure through Mar 2026 stood at $2.1 million (up 170.56% YoY), while the FY2025 annual figure was $893000.0, up 281.62% from the prior year.
- Shares Issued came in at $747000.0 for Q1 2026 at Rezolute, up from $356000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $49.2 million in Q1 2022 to a low of -$43.7 million in Q2 2022.
- A 4-year average of $2.3 million and a median of $747000.0 in 2026 frame the typical range for Shares Issued.
- Across the five-year window, Shares Issued soared 927.5% in 2022 and plunged 84.23% in 2025, its largest moves.
- Rezolute's Shares Issued stood at $12.3 million in 2022, then tumbled by 51.34% to $6.0 million in 2024, then plunged by 94.07% to $356000.0 in 2025, then surged by 109.83% to $747000.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $747000.0, $356000.0, and $946000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | 747,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 747,000.00 |
| Mar 31, 2026 | 747,000.00 |
| Dec 31, 2025 | 356,000.00 |
| Dec 31, 2025 | 356,000.00 |
| Sep 30, 2025 | 946,000.00 |
| Sep 30, 2025 | 946,000.00 |
| Jun 30, 2025 | 9,997.00 |
| Jun 30, 2025 | 9,997.00 |
| Mar 31, 2025 | -5.24 Mn |
| Mar 31, 2025 | -5.24 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Sep 30, 2022 | 12.33 Mn |
| Sep 30, 2022 | 12.33 Mn |
| Jun 30, 2022 | -43.69 Mn |
| Jun 30, 2022 | -43.69 Mn |
| Mar 31, 2022 | 49.24 Mn |
| Mar 31, 2022 | 49.24 Mn |
| Dec 31, 2021 | -9.30 Mn |
| Dec 31, 2021 | -9.30 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Dec 31, 2020 | 1.50 Mn |
| Dec 31, 2020 | 1.50 Mn |
| Jun 30, 2020 | 24.05 Mn |
| Jun 30, 2020 | 24.05 Mn |
| Dec 31, 2019 | -4.05 Mn |
| Dec 31, 2019 | -4.05 Mn |
| Sep 30, 2019 | 4.05 Mn |
| Sep 30, 2019 | 4.05 Mn |
| Sep 30, 2017 | 4.50 Mn |
| Sep 30, 2017 | 4.50 Mn |
| Jun 30, 2017 | 3.78 Mn |
| Jun 30, 2017 | 3.78 Mn |
| Mar 31, 2017 | 4.50 Mn |
| Mar 31, 2017 | 4.50 Mn |
| Dec 31, 2016 | 3.67 Mn |
| Dec 31, 2016 | 3.67 Mn |
| Sep 30, 2016 | 2.69 Mn |
| Sep 30, 2016 | 2.69 Mn |
| Jun 30, 2016 | 5.36 Mn |
| Jun 30, 2016 | 5.36 Mn |
| Mar 31, 2016 | -2.00 Mn |
| Mar 31, 2016 | -2.00 Mn |
| Dec 31, 2015 | 2.00 Mn |
| Dec 31, 2015 | 2.00 Mn |
| Jun 30, 2015 | 1.41 Mn |
| Jun 30, 2015 | 1.41 Mn |
| Mar 31, 2015 | 2.84 Mn |
| Mar 31, 2015 | 2.84 Mn |
| Jun 30, 2014 | 3.96 Mn |
| Jun 30, 2014 | 3.96 Mn |
| Mar 31, 2014 | 4.97 Mn |
| Mar 31, 2014 | 4.97 Mn |
| Sep 30, 2011 | 41,800.00 |
| Sep 30, 2011 | 41,800.00 |
| Dec 31, 2010 | 13,800.00 |
| Dec 31, 2010 | 13,800.00 |
| Sep 30, 2010 | 28,000.00 |
| Sep 30, 2010 | 28,000.00 |